Clinical Trial Update: Solriamfetol and CBT-I in Patients With Insomnia Disorder [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating solriamfetol in combination with CBT-I for insomnia disorder. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Sunosi (solriamfetol)

Snippet

Sponsor: University of Pennsylvania | Conditions: Insomnia | Phase 4 | Status: ACTIVE_NOT_RECRUITING